In Russia, a drug for the treatment of coronavirus based on the antimalarial drug mefloquine has been developed. This was reported by the press service of the Federal Biomedical Agency.
The research and production center “Farmzashchita” developed a treatment regimen taking into account Chinese and French experience.
“The drug with high selectivity blocks the cytopathic effect of coronavirus in cell culture and inhibits its replication, and the immunosuppressive effect of mefloquine prevents the activation of the inflammatory response caused by the virus. Adding macrolide antibiotics and synthetic penicillins not only prevents the formation of a secondary bacterial-viral syndrome but also increases the concentration of an antiviral agent in blood plasma and lungs, “said the head of the FMBA Veronika Skvortsova.
